The present study suggests that the mechanism by which aspirin and other NSAIDs exert an anti-tumor activity in the inflammatory chronic conditions was based on the neutralization of the p53 down-regulation and the consequent EMT activation, both induced by IL-6. This evidence concerns the gene TP53 and neoplasm.